|
Volumn 292, Issue 1-2, 2010, Pages 114-116
|
Guillain-Barré Syndrome as leading manifestation of Graft-versus-Host Disease in an allogeneic bone marrow transplanted patient
|
Author keywords
AlloBMT; Cyclosporine; GBS; GvHD; IVIg; Plasma exchange; Transplantation
|
Indexed keywords
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
IMMUNOGLOBULIN;
PREDNISONE;
RITUXIMAB;
VINCRISTINE SULFATE;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
ARTIFICIAL VENTILATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CASE REPORT;
DRUG TREATMENT FAILURE;
ELECTROMYOGRAM;
FEMALE;
GRAFT VERSUS HOST REACTION;
GUILLAIN BARRE SYNDROME;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
MUSCLE WEAKNESS;
NERVE CONDUCTION;
NEUROLOGIC EXAMINATION;
NONHODGKIN LYMPHOMA;
PARESTHESIA;
PHYSIOTHERAPY;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RASH;
SKIN BIOPSY;
THROMBOCYTOPENIA;
VITAL CAPACITY;
BONE MARROW TRANSPLANTATION;
FEMALE;
GRAFT VS HOST DISEASE;
GUILLAIN-BARRE SYNDROME;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOSUPPRESSIVE AGENTS;
MIDDLE AGED;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 77949872728
PISSN: 0022510X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jns.2010.01.020 Document Type: Article |
Times cited : (11)
|
References (9)
|